Smith & Nephew SNATS

Yahoo Finance • 3 days ago

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) code for procedures i... Full story

Yahoo Finance • 9 days ago

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound Journal,1 demonstrating the pressure in... Full story

Yahoo Finance • 11 days ago

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its CORIOGRAPH Pre-Op Planning a... Full story

Yahoo Finance • 11 days ago

Smith & Nephew Reaches Analyst Target Price

In recent trading, shares of Smith & Nephew plc (Symbol: SNN) have crossed above the average analyst 12-month target price of $35.55, changing hands for $36.29/share. When a stock reaches the target an analyst has set, the analyst logical... Full story

Yahoo Finance • 17 days ago

EU MedTech stocks down as U.S. launches national security probe into imports

[A magnifying glass placed in the scattered wooden letters] patpitchaya/iStock via Getty Images European MedTech stocks were trading lower on Thursday after the U.S. Department of Commerce launched a new national security investigation in... Full story

Yahoo Finance • last month

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant and support its further adoption. Substan... Full story

Yahoo Finance • last month

Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient’s own platelets and plasma that, once applie... Full story

Yahoo Finance • 2 months ago

Smith & Nephew stock hits 52-week high at 37.59 USD

Smith & Nephew SNATS Inc (SNN) stock reached a significant milestone by hitting a 52-week high at 37.59 USD. This achievement reflects the company’s robust performance over the past year, marked by a notable 21.78% increase in its stock pr... Full story

Yahoo Finance • 2 months ago

Global Surgical Sutures Market Poised to Reach USD 6.65 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The global surgical sutures market, valued at US$4.56 billion in 2024, stood at US$4.84 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culmin... Full story

Yahoo Finance • 2 months ago

Smith & Nephew Non-GAAP EPS of $0.43, revenue of $2.96B; reaffirms FY outlook

* Smith & Nephew press release [https://www.smith-nephew.com/en/who-we-are/investors/reports-and-presentations] (NYSE:SNN [https://seekingalpha.com/symbol/SNN]): 1H Non-GAAP EPSA of $0.43. * Revenue of $2.96B (+4.6% Y/Y). H1 underlying... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory

We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on Valueinvesting subreddit by KnowledgePatient7813. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.'s share was trading at $97.55 as... Full story

Yahoo Finance • 3 months ago

Smith & Nephew stock hits 52-week high at 31.72 USD

Smith & Nephew SNATS Inc (NYSE:SNN) stock reached a 52-week high of 31.72 USD, marking a significant milestone for the company. This achievement reflects a 10.35% increase over the past year, showcasing the company’s positive performance... Full story

Yahoo Finance • 6 months ago

Is Smith & Nephew plc (SNN) the Most Undervalued Healthcare Stock to Buy According to Analysts?

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Smith & Nephew plc (NYSE:SNN) stands against other most undervalued healthcare stocks... Full story

Yahoo Finance • 7 months ago

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual Mee... Full story

Yahoo Finance • last year

3 UK Stocks That Might Be Undervalued By Up To 49.8%

The London markets have recently experienced declines, with the FTSE 100 index closing lower due to weak trade data from China and a general dip in global economic confidence. Amid these challenging conditions, identifying undervalued stoc... Full story

Yahoo Finance • last year

Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board

Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and... Full story

Yahoo Finance • 2 years ago

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D... Full story

Yahoo Finance • 2 years ago

Charles Brandes Bolsters Portfolio with a Strategic Emphasis on Corteva Inc

Insight into the Investment Moves of a Value Investing Stalwart Charles Brandes (Trades, Portfolio), a seasoned value investor and founder of Brandes Investment Partners, has made notable changes to his investment portfolio in the fourth... Full story

Yahoo Finance • 2 years ago

Smith & Nephew plc's (LON:SN.) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Most readers would already be aware that Smith & Nephew's (LON:SN.) stock increased significantly by 22% over the past three months. However, in this article, we decided to focus on its weak fundamentals, as long-term financial performance... Full story

Yahoo Finance • 2 years ago

Is Smith & Nephew plc (LON:SN.) Trading At A 40% Discount?

Key Insights Smith & Nephew's estimated fair value is UK£17.05 based on 2 Stage Free Cash Flow to Equity Smith & Nephew's UK£10.21 share price signals that it might be 40% undervalued The US$12.68 analyst price target for SN. is 26% less... Full story